Compare TYRA & ECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TYRA | ECO |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2021 | 2023 |
| Metric | TYRA | ECO |
|---|---|---|
| Price | $33.86 | $54.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $47.50 | $42.00 |
| AVG Volume (30 Days) | ★ 997.4K | 327.3K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 6.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.07 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.75 | $21.27 |
| 52 Week High | $40.65 | $57.49 |
| Indicator | TYRA | ECO |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 58.90 |
| Support Level | $33.81 | $48.57 |
| Resistance Level | $33.99 | $57.29 |
| Average True Range (ATR) | 2.25 | 2.14 |
| MACD | -0.28 | 0.25 |
| Stochastic Oscillator | 16.55 | 69.50 |
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.